Novabay Pharmaceuticals, Inc. Announces Voluntarily Resignation of Wang Xu from Senior Manager and Controller, Effective as of July 23, 2021
June 30, 2021 at 04:30 pm EDT
Share
On June 29, 2021, Wang Xu, a named executive officer of NovaBay Pharmaceuticals, Inc., voluntarily resigned as the Company’s Senior Manager and Controller to be effective as of July 23, 2021. The Company has started its search for a permanent replacement for Ms. Xu whose duties will be handled in the interim by existing company resources and/or a temporary consultant.
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells consumer products for the eyecare and skincare markets. The Company's lead product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have antimicrobial properties as it removes foreign material, such as microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with its form of hypochlorous acid and is cleared by the United States Food and Drug Administration (FDA) for sale in the United States. Its other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress and the i-Chek. Avenova Spray is available both over-the-counter and as a prescription. Avenova Spray is also available at optometrists and ophthalmologists offices; at national pharmacy chains across all over 50 states, and through its Partner Pharmacy Program.
NOVABAY PHARMACEUTICALS 
